The aim of this work was to demonstrate the advantages of using telemedicine (TM) in the management of the outpatients with maxillofacial surgical pathologies during the COVID-19 pandemic. The study was conducted at the MaxilloFacial Surgery Unit of “Magna Graecia” University of Catanzaro, on two different groups of patients: a group of follow-up patients (A1: patients in oncological follow-up after surgical treatment performed before the COVID-19 pandemic; A2: suffering from chronic lesions such as precancerous lesions), and a group B of patients with first urgent visits (B1: patients with suspected oncological pathology; B2: patients with suspected urgent disease such as medication-related osteonecrosis of the jaws (MRONJ), odontogenic abscesses, temporomandibular joint (TMJ) dislocation, etc.). Participation in the study required possession of a smartphone with Internet access, e-mail and the use of a messaging service (WhatsApp or Telegram) to send photos and messages; completion by the patient of a COVID-19 screening questionnaire; submission of a satisfaction questionnaire by the doctors and patients. A total of 90 patients were included in this study. A high percentage of satisfaction emerged from the analysis of the satisfaction questionnaires of both patients and doctors.TM thus represents an excellent opportunity to improve accessibility to oncological and non-management activities, reducing the risk of Covid-19 dissemination and should be promoted and implemented in the post-pandemic era.

No abstract

Dentinogenic ghost cell tumor (DGCT) is a rare benign tumorous form of calcifying odontogenic cyst (COC) characterized by the presence of ghost cells but it seems to have more aggressive behavior. It represents 11.5% of COCs. In this work, we report a case of a 60-year-old male patient with DGCT in the posterior region of the right mandible treated with surgical enucleation.

Prostate cancer is the most frequently diagnosed cancer in men and the second leading cause of cancer death among men in the United States. The most common site of prostate cancer metastasis is the bone, with skeletal metastases identified at autopsy in up to 90% of patients dying from prostate cancer. The route of metastasis to bone is thought the prostatic venous plexus draining with the vertebral veins. In this report jaw bones metastases occur before the patient has been diagnosed a primary tumour; in a smaller rate their diagnoses coincides with the diagnosis of the primary tumour. Data reported in literature a low incidence of jaw bones metastases; they are even less recurrent in mandibular condyles owing to their low red bone marrow (hematopoietic active) content in adulthood. Just in a few exceptional cases, like this case, bone metastases is the first clinical evidence of an occult or initial cancer, a site occurs above all in prostate, bladder and lung cancer. Our case are exceptional because the mandibular condyle metastasis was the first clinical sign of an occult primary prostate carcinoma, whose early diagnosis made the treatment of both (primary tumour and sigle metastasis) more effective.

No abstract